Review of dose–response curves for acute antimigraine drugs: triptans, 5-HT1Fagonists and CGRP antagonists
Author:
Publisher
Informa Healthcare
Subject
Pharmacology,Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.1055244
Reference60 articles.
1. Migraine: the seventh disabler
2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
3. Migraine prevalence, disease burden, and the need for preventive therapy
4. Efficacy and safety of 1,000mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Herbal medicines for insomnia through regulating 5-hydroxytryptamine receptors: a systematic review;Chinese Journal of Natural Medicines;2023-07
2. Ubrogepant;Novel Synthetic Drugs in Migraine;2022
3. Subcutaneous sumatriptan reduces cilostazol induced headache in migraine patients;Cephalalgia;2020-03-26
4. Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success;Journal of Medicinal Chemistry;2020-02-14
5. Ubrogepant for the treatment of migraine;Expert Opinion on Pharmacotherapy;2020-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3